Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLWL-01 in Overweight/Obese and Type 2 Diabetes
NCT02377362Phase 1Terminated
- Sponsor
- GLWL Research, Inc.
- Start
- Mar 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of GLWL-01 in type 2 diabetes mellitus (T2DM) (6 arms), sponsored by GLWL Research, Inc. Primary endpoint: Number of Participants With One or More Treatment Emergent Adverse Events. Started Mar 2015; status: terminated.
02
Drugs
GLWL-01
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02377362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02377362.